达帕格利弗洛辛通过miR-155-5p/HO-1/NLRP3轴调节来防止脏细胞的灭
Zhen-Wang Zhang1, Ming-Qiu Tang2, Wu Liu1
1Medicine Research Institute & Hubei Key Laboratory of Diabetes and Angiopathy, Hubei University of Science and Technology, Xianning 437000, PR China.
International immunopharmacology
|March 13, 2024
概括
达帕格利弗洛辛通过抑制细胞死亡途径 - - 热亡 - - 减少糖尿病小鼠的损伤. 这种药物向miR-155-5p/HO-1/NLRP3通路,为糖尿病病提供了潜在的治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病病 (DN) 是慢性功能衰竭的主要原因.
- 炎症性细胞死亡的一种形式热,越来越多地与糖尿病 (DM) 的进展有关.
- 灭酶在DN中的作用及其潜在机制仍然不清楚.
研究的目的:
- 为了研究达帕格利弗洛辛在糖尿病病中的抗火性作用.
- 阐明涉及达帕格利弗洛辛对DN的保护作用的分子途径.
主要方法:
- 实验中使用2型糖尿病小鼠进行了治疗,这些小鼠接受了达帕格利弗洛辛的治疗.
- 评估了与热死相关的基因表达和脏组织损伤.
- 在体外研究中,使用棕酸处理的小鼠细胞来检查分子机制.
主要成果:
- 在糖尿病小鼠中,达帕格利弗洛辛治疗显著减少了组织损伤.
- 达帕格利弗洛辛减弱了关键的烧亡标记物的表达 (ASC,分裂的Caspase-1,GSDMD,NLRP3,IL-18,IL-1β).
- 在体外,达帕格利弗洛辛表现出类似的抗火性作用,通过miR-155-5p/HO-1/NLRP3轴介导.
结论:
- 达帕格利弗洛辛通过miR-155-5p/HO-1/NLRP3通路抑制糖尿病病中的细胞灭.
- 达帕格利弗洛辛代表了一种有前途的治疗策略,用于预防炎和治疗DN.
更多相关视频
相关概念视频
01:23Dipeptidyl Peptidase 4 Inhibitors
184
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
184
01:24Glucagon-like Receptor Agonists
321
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
321
01:10Nephrons
2.4K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.4K
01:06Oral Hypoglycemic Agents: Glinides
154
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
154
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K